Jen-Liang Su - Search Results

Year	Number of Results
2003	3
2004	4
2005	4
2006	2
2007	4
2008	2
2009	2
2010	4
2011	4
2012	6
2013	2
2014	10
2015	4
2016	4
2017	6
2019	2
2024	0

1

Function and regulation of let-7 family microRNAs.

Su JL, Chen PS, Johansson G, Kuo ML. Su JL, et al. Microrna. 2012;1(1):34-9. doi: 10.2174/2211536611201010034. Microrna. 2012. PMID: 25048088 Review.

2

Dysregulation of microRNAs in cancer.

Chen PS, Su JL, Hung MC. Chen PS, et al. Among authors: su jl. J Biomed Sci. 2012 Oct 17;19(1):90. doi: 10.1186/1423-0127-19-90. J Biomed Sci. 2012. PMID: 23075324 Free PMC article. Review.

3

The anti-tumor activity of E1A and its implications in cancer therapy.

Chang YW, Hung MC, Su JL. Chang YW, et al. Among authors: su jl. Arch Immunol Ther Exp (Warsz). 2014 Jun;62(3):195-204. doi: 10.1007/s00005-014-0273-2. Epub 2014 Feb 7. Arch Immunol Ther Exp (Warsz). 2014. PMID: 24504082 Free article. Review.

4

The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.

Chen JC, Chang YW, Hong CC, Yu YH, Su JL. Chen JC, et al. Among authors: su jl. Int J Mol Sci. 2012 Dec 20;14(1):88-107. doi: 10.3390/ijms14010088. Int J Mol Sci. 2012. PMID: 23344023 Free PMC article. Review.

5

Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling.

Yeh YW, Cheng CC, Yang ST, Tseng CF, Chang TY, Tsai SY, Fu E, Chiang CP, Liao LC, Tsai PW, Yu YL, Su JL. Yeh YW, et al. Among authors: su jl. Oncotarget. 2017 Jan 17;8(3):5603-5618. doi: 10.18632/oncotarget.13629. Oncotarget. 2017. PMID: 27901498 Free PMC article. Review.

6

FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization.

Su JL, Cheng X, Yamaguchi H, Chang YW, Hou CF, Lee DF, Ko HW, Hua KT, Wang YN, Hsiao M, Chen PB, Hsu JM, Bast RC Jr, Hortobagyi GN, Hung MC. Su JL, et al. Cancer Res. 2011 Nov 1;71(21):6878-87. doi: 10.1158/0008-5472.CAN-11-0295. Epub 2011 Sep 12. Cancer Res. 2011. PMID: 21911455 Free PMC article.

7

Retraction: Knockdown of Contactin-1 Expression Suppresses Invasion and Metastasis of Lung Adenocarcinoma.

Su JL, Yang CY, Shih JY, Wei LH, Hsieh CY, Jeng YM, Wang MY, Yang PC, Kuo ML. Su JL, et al. Cancer Res. 2019 Jul 15;79(14):3793. doi: 10.1158/0008-5472.CAN-19-1711. Cancer Res. 2019. PMID: 31308141 No abstract available.

8

Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects.

Chang YW, Su CM, Su YH, Ho YS, Lai HH, Chen HA, Kuo ML, Hung WC, Chen YW, Wu CH, Chen PS, Su JL. Chang YW, et al. Among authors: su jl. Oncotarget. 2014 Jun 15;5(11):3823-35. doi: 10.18632/oncotarget.1709. Oncotarget. 2014. PMID: 25003617 Free PMC article.

9

NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance.

Chiu CF, Chang YW, Kuo KT, Shen YS, Liu CY, Yu YH, Cheng CC, Lee KY, Chen FC, Hsu MK, Kuo TC, Ma JT, Su JL. Chiu CF, et al. Among authors: su jl. Proc Natl Acad Sci U S A. 2016 May 3;113(18):E2526-35. doi: 10.1073/pnas.1522612113. Epub 2016 Apr 18. Proc Natl Acad Sci U S A. 2016. PMID: 27091996 Free PMC article.

10

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.

Kuo TC, Tan CT, Chang YW, Hong CC, Lee WJ, Chen MW, Jeng YM, Chiou J, Yu P, Chen PS, Wang MY, Hsiao M, Su JL, Kuo ML. Kuo TC, et al. Among authors: su jl. J Clin Invest. 2013 Mar;123(3):1082-95. doi: 10.1172/JCI64044. Epub 2013 Feb 22. J Clin Invest. 2013. PMID: 23434592 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

61 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year